CVR 27744532Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)København SFounded 17 May 2004
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about SANDOZ A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
118
CVR, Aug 2026
0 (0%) over 12 months
Revenue
2.5B
DKK, annual report 2025
-0.3% on 2024
Result
+85.2M
DKK, annual report 2025
Equity
662.8M
DKK, annual report 2025
Sandoz AG100% of capital and votes, since 24 Mar 2023
Operating company
Dandex estimate: 118 employees registered in 2026Lawrence Edward Meadsince 14 May 2025
100% of capital and votessince 24 Mar 2023
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 20575786100% of capital and votesnotified 24 Mar 202330 Jun 2004 to 24 Mar 2023
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
30 May 2022 to 13 Nov 2026.
17 May 2004 to 13 Nov 2026. Showing 25 of 33. The list above has every one.
Aug 2026, monthly: 118 employees, 101 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 60 | 71 | 270 | 164 | 112 | 62 | No count | No count | No count | No count | 63 | 65 | 90 | 95 | 103 | 103 | 115 | 106 | 106 | 101 | 102 | 104 | 109 | 110 | 112 | 113 | 120 | 126 | 144 | 128 | 122 | 120 | 129 | 129 | 128 | 129 | 130 | 129 | 129 | 129 | 149 | 128 | 129 | 126 | 130 | 132 | 129 | 130 | 136 | 135 | 132 | 129 | 154 | 133 | 129 | 130 | 136 | 129 | 136 | 133 | 137 | 137 | 128 | 130 | 141 | 126 | 126 | 121 | 123 | 122 | 121 | 122 | 119 | 117 | 117 | 113 | 140 | 112 | 112 | 111 | 111 | 112 | 113 | 113 | 107 | 108 | 109 | 109 | 127 | 119 | 112 | 117 | 118 | 123 | 120 | 123 | 122 | 118 | 121 | 117 | 135 | 119 | 121 | 127 | 120 | 122 | 124 | 119 | 116 | 119 | 124 | 126 | 150 | 121 | 123 | 124 | 127 | 127 | 125 | 122 | 124 | 121 | 121 | 118 | 142 | 123 | 124 | 123 | 124 | 121 | 122 | 121 | 117 | 119 | 118 | 121 | 138 | 118 | 117 | 117 | 117 | 118 | 118 | 120 | 119 | 136 | 125 | 122 | 136 | 120 | 139 | 122 | 119 | 118 |
| FTE | 53 | 59 | 264 | 186 | 117 | 69 | 51 | 56 | 59 | 58 | 67 | 74 | 78 | 92 | 100 | 99 | 109 | 101 | 103 | 100 | 94 | 100 | 107 | 106 | 109 | 110 | 116 | 119 | 132 | 119 | 114 | 113 | 113 | 113 | 112 | 113 | 114 | 113 | 111 | 111 | 126 | 110 | 112 | 111 | 115 | 115 | 116 | 115 | 120 | 118 | 113 | 110 | 128 | 114 | 114 | 117 | 117 | 116 | 120 | 119 | 121 | 121 | 114 | 114 | 121 | 110 | 110 | 108 | 108 | 106 | 107 | 102 | 107 | 105 | 102 | 101 | 122 | 100 | 97 | 100 | 97 | 98 | 96 | 98 | 96 | 97 | 97 | 98 | 107 | 104 | 101 | 102 | 103 | 104 | 104 | 106 | 105 | 103 | 104 | 108 | 120 | 107 | 107 | 110 | 106 | 104 | 105 | 104 | 102 | 107 | 109 | 109 | 127 | 107 | 107 | 107 | 106 | 108 | 107 | 103 | 105 | 105 | 103 | 105 | 118 | 105 | 109 | 108 | 107 | 104 | 106 | 104 | 102 | 107 | 101 | 105 | 119 | 104 | 101 | 102 | 100 | 101 | 102 | 103 | 105 | 109 | 107 | 106 | 113 | 105 | 112 | 106 | 101 | 101 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2004 to 2009 and 2011 to 2014; quarterly Q1 2010 to Q4 2010; monthly Jan 2015 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2,011,917 | 2,163,937 | 2,291,832 | 2,523,029 | 2,515,342 |
| Operating profit | +75,574 | +83,483 | +84,503 | +72,089 | +93,431 |
| Result for the year | +58,023 | +42,920 | +68,521 | +48,047 | +85,168 |
| Equity | 418,136 | 461,056 | 529,577 | 577,624 | 662,792 |
| Total assets | 1,015,689 | 1,174,038 | 1,443,702 | 1,535,740 | 1,521,347 |
| Employees (average) | 104 | 106 | 149 | 141 | 137 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -5.6% | 7.6% | 5.9% | 10.1% | -0.3% |
| EBIT margin (overskudsgrad) | 3.8% | 3.9% | 3.7% | 2.9% | 3.7% |
| EBITDA | 77,740 | 85,270 | 86,235 | 74,134 | 94,218 |
| EBITDA margin (EBITDA-margin) | 3.9% | 3.9% | 3.8% | 2.9% | 3.8% |
| Employee growth (vækst i antal ansatte) | 4% | 1.9% | 40.6% | -5.4% | -2.8% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 17note 1 | 0note 2 | 959note 1 | 1,467note 1 | 173note 1 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 25 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 15 May 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 14 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 11 May 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 30 Jun 2022
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For SANDOZ A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
Merger (fusion), as the continuing company (fortsættende selskab)
Demerger (spaltning), as the receiving company (modtagende selskab)
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
45 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Kerstin Elisabeth Jarvheden, den 16.06.2025.
Tiltrådte:
Lawrence Edward Mead, den 16.06.2025.
Direktion:
Fratrådte:
Kerstin Elisabeth Jarvheden, (adm. dir), den 14.05.2025.
Tiltrådte:
Lawrence Edward Mead, (adm. dir), den 14.05.2025.
Bestyrelse:
Fratrådte:
Christophe Delenta, (formand), den 15.01.2025.
Tiltrådte:
Diane Marie DiGangi, (formand), den 15.01.2025.
Bestyrelse:
Fratrådte:
Carsten Gleerup, den 15.01.2025.
Bestyrelsessuppleanter:
Fratrådte:
Aljoscha Boris Patrick Stroh, den 15.01.2025.
Direktion:
Fratrådte:
Carsten Gleerup, (adm. dir), den 01.01.2025.
Tiltrådte:
Elisabeth Kerstin Jarvheden, (adm. dir), den 01.01.2025.
Bestyrelse:
Fratrådte:
Rebecca Flückiger Guntern, (formand), den 19.09.2024.
Tiltrådte:
Christophe Delenta, (formand), den 19.09.2024.
Revision:
Fratrådte:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 25.01.2023.
Tiltrådte:
CVR-NR. 25578198 KPMG P/S, Dampfærgevej 28, 2100 København Ø, den 25.01.2023.
Bestyrelse:
Fratrådte:
Adri Mussolini Simamora, den 13.01.2023.
Tiltrådte:
Nete Brændgaard, den 13.01.2023.
Bestyrelsessuppleanter:
Bestyrelse:
Fratrådte:
Judith Louise Love, den 30.05.2022.
Tiltrådte:
Adri Mussolini Simamora, den 30.05.2022.
Bestyrelsessuppleanter:
Tiltrådte:
Nete Brændgaard, den 30.05.2022.
Bestyrelse:
Fratrådte:
Martin Bischof, (formand), den 30.09.2020.
Tiltrådte:
Rebecca Flückiger Guntern, (formand), den 30.09.2020.
Bestyrelse:
Fratrådte:
Francesco Balestrieri, (formand), den 30.09.2019, Knut Ulrich Mager, den 30.09.2019.
Tiltrådte:
Carsten Gleerup, den 30.09.2019, Martin Bischof, (formand), den 30.09.2019.
Bestyrelse:
Fratrådte:
Niklas Olof Karlberg, den 10.05.2019.
Tiltrådte:
Judith Louise Love, den 10.05.2019.
Bestyrelse:
Fratrådte:
Pierluigi Antonelli, (formand), den 31.10.2018.
Tiltrådte:
Francesco Balestrieri, (formand), den 31.10.2018.
Direktion:
Fratrådte:
Alexander Krujatz, (adm. dir), den 01.11.2018.
Tiltrådte:
Carsten Gleerup, (adm. dir), den 01.11.2018.
Bestyrelse:
Fratrådte:
Nicholas Robert Haggar (formand), den 31.08.2015.
Tiltrådte:
Pierluigi Antonelli (formand), den 31.08.2015.
CVR-nummer:
27744532.
NAVN:
SANDOZ A/S.
Adresse: Edvard Thomsens Vej 14, 1., 2300 København S.
Kommune: København.
Direktion:
Fratrådte:
Rex Bernard Clements (adm. dir), den 11.05.2015.
Tiltrådte:
Alexander Krujatz (adm. dir), den 11.05.2015.
Direktion:
Udtrådt af direktionen:
Paul Geymayer, den 06.01.2014.
Indtrådt i direktionen:
Rex Bernard Clements (adm. dir), den 06.01.2014.
Direktion:
Udtrådt af direktionen:
Ken Rasmussen, den 05.11.2012.
Indtrådt i direktionen:
Paul Geymayer (adm. dir), den 05.11.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Jean-Claude Dubos, den 30.07.2012.
Indtrådt i bestyrelsen:
Sue Webb, den 30.07.2012.
Ny adresse:
Edvard Thomsens Vej 14, 1., 2300 København S.
Bestyrelse:
Udtrådt af bestyrelsen:
Ken Rasmussen, den 21.06.2011, Thomas Weigold, den 21.06.2011.
Indtrådt i bestyrelsen:
Niklas Olof Karlberg, den 21.06.2011.
Bestyrelse:
Udtrådt af bestyrelsen:
Eric Gorka, den 31.12.2010.
Indtrådt i bestyrelsen:
Nicholas Robert Haggar (formand), den 03.01.2011.
Vedtægter ændret:
26.05.2010.
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af en direktør i forening med et bestyrelsesmedlem.
Vedtægter ændret:
03.09.2009.
Kapitalforhøjelse:
kr. 2.000.000,00 indbetalt ved konvertering af gæld, kurs 20.000,00.
Kapitalen udgør herefter kr. 12.000.000,00.
Direktion:
Udtrådt af direktionen:
Olof Johannes Milveden, den 20.05.2009.
Indtrådt i direktionen:
Ken Rasmussen, den 20.05.2009.
Bestyrelse:
Tiltrådt som formand:
Eric Gorka, den 30.03.2009, Fratrådt som formand, men forbliver i bestyrelsen: Ken Rasmussen, den 30.03.2009.
Indtrådt i bestyrelsen:
Thomas Weigold, den 30.03.2009.
Vedtægter ændret:
13.02.2009.
Ny adresse:
Edvard Thomsens Vej 14, 7., 2300 København S.
Ny kommune:
København.
Revision:
Udtrådt af revisionen:
PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab, den 30.06.2005.
Indtrådt i revisionen:
CVR-NR. 16994294 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, Strandvejen 44, 2900 Hellerup, den 30.06.2005.
Vedtægter ændret:
20.12.2007.
Kapitalforhøjelse:
kr. 2.015.000,00 indbetalt ved konvertering af gæld, kurs 14.888,33.
Kapitalen udgør herefter kr. 10.000.000,00.
Direktion:
Udtrådt af direktionen:
Håkan Josephson, den 30.10.2007.
Indtrådt i direktionen:
Olof Johannes Milveden, den 30.10.2007.
Direktion:
Udtrådt af direktionen:
Jens Piilgaard Nielsen, den 20.04.2007.
Indtrådt i direktionen:
Håkan Josephson, den 20.04.2007.
Aktiver og gæld er overdraget til CVR-NR. 30489411 GEA PHARMACEUTICAL A/S.
Erhvervs- og Selskabsstyrelsen har modtaget
spaltningsplan i henhold til aktieselskabslovens § 136 a
angående den påtænkte spaltning af
CVR-NR. 27744532 SANDOZ A/S. der tillige driver virksomhed under navnene DURASCAN A/S (SANDOZ A/S), DURASCAN MEDICAL PRODUCTS A/S (SANDOZ A/S), HEXAL SCANDINAVIA A/S (SANDOZ A/S), HEXAL A/S (SANDOZ A/S), 1A FARMA A/S (SANDOZ A/S), BIOCUR A/S (SANDOZ A/S), A/S GEA - DET DANSKE ALTERNATIV (SANDOZ A/S), A/S GEA FARMACEUTISK FABRIK (SANDOZ A/S).
De øvrige deltagende selskaber er et/flere
nye selskaber.
Endvidere er modtaget erklæring fra
vurderingsmændene i henhold til aktieselskabslovens §
136 c, stk. 4.
Vedtægter ændret:
01.09.2006.
Nye binavne:
HEXAL SCANDINAVIA A/S (SANDOZ A/S), HEXAL A/S (SANDOZ A/S), 1A FARMA A/S (SANDOZ A/S), BIOCUR A/S (SANDOZ A/S), A/S GEA - DET DANSKE ALTERNATIV (SANDOZ A/S), A/S GEA FARMACEUTISK FABRIK (SANDOZ A/S).
Kapitalforhøjelse:
kr. 2.985.000,00 indbetalt ved fusion, kurs 1.582,71.
Kapitalen udgør herefter kr. 7.985.000,00.
Selskabet er fusioneret med CVR-NR. 62970715 HEXAL A/S, CVR-NR. 25538846 1A FARMA A/S, CVR-NR. 10024951 BIOCUR A/S, CVR-NR. 19783472 HEXAL SCANDINAVIA A/S, der samtidig er opløst.
Erhvervs- og Selskabsstyrelsen har modtaget
fusionsplan i henhold til aktieselskabslovens § 134 a
for fusion mellem
CVR-NR. 27744532 SANDOZ A/S. der tillige driver virksomhed under navnene DURASCAN A/S (SANDOZ A/S), DURASCAN MEDICAL PRODUCTS A/S (SANDOZ A/S).
CVR-NR. 25538846 1A FARMA A/S.
CVR-NR. 10024951 BIOCUR A/S.
Bestyrelse:
Udtrådt af bestyrelsen:
Christopher Lewis Kaplan, den 14.03.2006, Hari Sven Venkita Ayer Krishnan, den 14.03.2006, Andreas Strüngmann, den 14.03.2006.
Indtrådt i bestyrelsen:
Ken Rasmussen (formand), den 14.03.2006, Eric Gorka, den 14.03.2006.
Bestyrelse:
Udtrådt af bestyrelsen:
Hubert Hirzinger, den 02.11.2005.
Indtrådt i bestyrelsen:
Andreas Strüngmann, den 02.11.2005.
Bestyrelse:
Udtrådt af bestyrelsen:
Hari Sven Venkita Ayer Krishnan, den 02.11.2005.
Indtrådt i bestyrelsen:
Hari Sven Venkita Ayer Krishnan, 1856 Frederiksberg C, den 02.11.2005.
Bestyrelse:
Udtrådt af bestyrelsen:
Jan Oluf Eriksson, den 25.05.2005, Alexander David Hardy, den 25.05.2005.
Indtrådt i bestyrelsen:
Christopher Lewis Kaplan (formand), den 25.05.2005, Hari Sven Venkita Ayer Krishnan, den 25.05.2005.
Vedtægter ændret:
11.10.2004.
Nyt navn:
SANDOZ A/S.
Binavn:
DURASCAN A/S (SANDOZ A/S).
Nyt binavn: DURASCAN MEDICAL PRODUCTS A/S (SANDOZ A/S).
Bestyrelse:
Udtrådt af bestyrelsen:
Lone Aagaard, den 30.06.2004, Carit Jacques Andersen, den 30.06.2004, Jens Piilgaard Nielsen, den 30.06.2004.
Indtrådt i bestyrelsen:
Jan Oluf Eriksson (formand), den 30.06.2004, Jean-Claude Dubos, den 30.06.2004, Alexander David Hardy, den 30.06.2004, Hubert Hirzinger, den 30.06.2004.
Revision:
Udtrådt af revisionen:
KPMG C. Jespersen Statsautoriseret revisorinteressentskab, den 30.06.2004.
Indtrådt i revisionen:
PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab, Strandvejen 44, 2900 Hellerup, den 30.06.2004.
Binavn:
DURASCAN A/S (DURASCAN MEDICAL PRODUCTS A/S).
Selskabet er stiftet ved spaltning, den 17.05.2004 Selskabets aktiver og gæld er overdraget fra CVR-NR. 55742928 ASTRAZENECA A/S.
Seneste vedtægtsdato:
17.05.2004.
Kapital:
kr. 5.000.000,00.
Indbetalingsmåde:
spaltning kr. 5.000.000,00 til kurs 1.133,68.
Bestyrelse:
Direktør Lone Aagaard, 4681 Herfølge, den 17.05.2004, Økonomidirektør Carit Jacques Andersen, 5220 Odense SØ, den 17.05.2004, Jens Piilgaard Nielsen, 4000 Roskilde, den 17.05.2004.
Direktion:
Jens Piilgaard Nielsen, 4000 Roskilde, den 17.05.2004.
Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af tre medlemmer af bestyrelsen i forening eller af den samlede bestyrelse.
Revision:
KPMG C. Jespersen Statsautoriseret revisorinteressentskab, Borups Alle 177, postboks 250, 2000 Frederiksberg, den 17.05.2004.
Første regnskabsår:
01.01.2004 - 31.12.2004.
Regnskabsår:
01.01 - 31.12.
9 registered in CVR.
P-number 1015088148Edvard Thomsens Vej 14, 2300 København S
P-number 1010574141C.F. Tietgens Boulevard 40, 5220 Odense SØ
P-number 1012553222Herstedøstervej 27, 2620 Albertslund
P-number 1015257705Herstedøstervej 27, 2620 Albertslund
P-number 1015155457C.F. Tietgens Boulevard 40, 5220 Odense SØ
P-number 1002885258C.F. Tietgens Boulevard 40, 5220 Odense SØ
P-number 1015257675Kanalholmen 8, 2650 Hvidovre
P-number 1003151615Stamholmen 151, 2650 Hvidovre
P-number 1003151627Edvard Thomsens Vej 14, 2300 København S
No other current company drawn.
No other current company drawn.
No other current company drawn.